2 recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow [18F]FAPI-74: new trials by email Literature Review of [18F]FAPI-74 trials Research Report on [18F]FAPI-74
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging [18F]FAPI-74, 18F-FAPI-74 PET/CT Imaging - Allogeneic Stem Cell Transplantation, Lung Allograft Transplantation | Phase 3 | Recruiting | National Heart, Lung, and Blood Institute (NHLBI) | 210 | 2026-09-18 | 2026-10-26 |
| 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection [18F]FAPI-74, [18F]FDG - Sarcoma, Small Cell Lung Cancer or Extrapulmonary Neuroendocrine Cancer (EP-NEC) | Phase 2 | Recruiting | National Cancer Institute (NCI) | 320 | 2025-09-09 | 2026-05-19 |
Acute Lung Injury (1) · Carcinoma, Hepatocellular (1) · Cardiovascular Diseases (1) · Cholangiocarcinoma (1) · Lung Diseases, Interstitial (1) · Mesothelioma (1) · Ovarian Neoplasms (1) · Paraganglioma (1) · Pheochromocytoma (1) · Pulmonary Arterial Hypertension (1) · Sarcoma (1) · Small Cell Lung Carcinoma (1) · Stomach Neoplasms (1) · Urinary Bladder Neoplasms (1)
National Cancer Institute (NCI) (1) · National Heart, Lung, and Blood Institute (NHLBI) (1)
United States (2)
Anthony F Suffredini, M.D. (1) · Esther Mena Gonzalez, M.D. (1)